Seminars in Pediatric Neurology
Volume 16, Issue 3 , Pages 120-126, September 2009

Genetics and Biology of Microcephaly and Lissencephaly

  • Ganeshwaran H. Mochida, MD, MMSc

      Affiliations

    • Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA
    • Pediatric Neurology Unit, Massachusetts General Hospital, Boston, MA
    • Division of Genetic and Manton Center for Orphan Disease Research, Children's Hospital Boston, Boston, MA
    • Corresponding Author InformationAddress reprint requests to Ganeshwaran H. Mochida, MD, MMSc, Department of Neurology, Beth Israel Deaconess Medical Center, 3 Blackfan Circle, CLS630, Boston, MA 02115

Genetic microcephaly and lissencephaly are 2 of the most common brain malformations. Each of them is a heterogeneous group of disorders caused by mutations of many different genes. They are a significant cause of neurological morbidity in children worldwide, responsible for many cases of mental retardation, cerebral palsy, and epilepsy. Recent advances in molecular genetics have led to the identification of several genes causing these disorders, and thus accurate molecular diagnosis and improved genetic counseling has become available for many patients and their families. More recently identified genes include STIL, causing primary autosomal recessive microcephaly (microcephaly vera), and TUBA1A, causing lissencephaly. Numerous other disease genes are likely still to be identified. Functional studies of genes that cause microcephaly and lissencephaly have provided valuable insight into the molecular mechanisms of human brain development.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 10.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by grants from NIH/NINDS (R37NS35129), the Dubai Harvard Foundation for Medical Research, and the Manton Center for Orphan Disease Research.

PII: S1071-9091(09)00044-8

doi:10.1016/j.spen.2009.07.001

Seminars in Pediatric Neurology
Volume 16, Issue 3 , Pages 120-126, September 2009